More Good News On Actemra In Severe COVID-19 – But Will Roche File For Approval?
Another Significant RECOVERY Result
The RECOVERY trial has found Actemra to help cut deaths and speed recovery – and UK doctors are not waiting for Roche to complete own studies.
You may also be interested in...
AstraZeneca and BioNTech are both boosting production of their vaccines in Europe, and the first batches of Comirnaty have arrived in Australia and New Zealand.
After failing in five earlier trials, Actemra shows significant life-saving benefits for patients with severe COVID-19.
A rush of additional orders from countries around the world has boosted the company’s prospects, and fueled its ambitions beyond COVID-19.